Overview
Helen Parker practices in Manchester, United Kingdom. Ms. Parker is rated as a Distinguished expert by MediFind in the treatment of Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). Her top areas of expertise are Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), Mucopolysaccharidoses (MPS), and Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B).
Her clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)
- Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)
- Advanced
- Mucopolysaccharidoses (MPS)Ms. Parker isAdvanced. Learn about Mucopolysaccharidoses (MPS).
- Experienced
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B)